Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares in the company, valued at $29,740,135.88. This represents a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Axon Enterprise Price Performance
NASDAQ AXON opened at $569.81 on Thursday. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The company has a market cap of $45.81 billion, a PE ratio of 374.88, a PEG ratio of 12.36 and a beta of 1.46. The stock’s 50-day moving average price is $536.69 and its two-hundred day moving average price is $620.70.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. During the same period last year, the firm posted $2.08 earnings per share. The firm’s quarterly revenue was up 38.5% compared to the same quarter last year. On average, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Hedge Funds Weigh In On Axon Enterprise
Axon Enterprise News Roundup
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: February quarter beat: Axon reported upside to EPS and revenue (strong ARR/subscription growth and bookings highlighted on the earnings call), reinforcing the company’s SaaS-like recurring revenue narrative and supporting future growth expectations. Earnings Call Highlights
- Positive Sentiment: Analyst bullishness: TD Cowen and other brokers have raised price targets and reiterated buy/outperform views after strong bookings and ARR trends (TD Cowen raised its target), giving institutional support to the bull case. Price Target Raised After Strong Bookings Growth
- Neutral Sentiment: Investor outreach/visibility: Management presented at the Morgan Stanley TMT conference — useful for investor engagement but the transcript did not contain new guidance or surprises that would immediately re-rate the stock. Conference Presentation Transcript
- Neutral Sentiment: Market commentary is mixed: post-earnings coverage praises growth (Axon 911, ARR) but flags a very rich forward multiple, meaning the stock needs continued execution to justify valuation. Zacks and other roundups mention Axon among featured ideas but do not change near-term fundamentals. Zacks Investment Ideas
- Negative Sentiment: Insider selling: Director/insider Isaiah Fields sold 2,000 shares (~$535 avg), trimming his stake — such sales can be perceived negatively and add pressure to sentiment. SEC Filing — Fields Sale
- Negative Sentiment: Additional insider sale: CAO Jennifer H. Mak sold 1,500 shares at roughly $573.45, further signaling insiders taking chips off the table. SEC Filing — Mak Sale
- Negative Sentiment: Aggregated coverage (TipRanks, MarketBeat) notes multiple insider sales in a short window, which can amplify investor concern about near-term selling pressure even if trades are modest. Insider Sales Coverage
Analysts Set New Price Targets
Several research analysts recently weighed in on the company. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Piper Sandler dropped their target price on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. UBS Group decreased their price target on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a report on Wednesday, February 25th. Royal Bank Of Canada lowered their price objective on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Finally, Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research report on Tuesday, January 6th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $762.93.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
- Five stocks we like better than Axon Enterprise
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
